Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.

Abstract

PURPOSE:

To describe the role of triple agent immunosuppression in severe recalcitrant cases of Vogt-Koyanagi-Harada syndrome.

MATERIALS AND METHODS:

Retrospective chart review of five cases of Vogt-Koyanagi-Harada syndrome.

RESULTS:

All cases were treated with oral prednisolone, azathioprine, and cyclosporine in combination, and rapid remission was observed in all patients. The synergistic effect of the triple agent immunosuppressives helped in preventing recurrences. Prolonged treatment with steroid sparing immunosuppressives in severe and recalcitrant cases of Vogt-Koyanagi-Harada syndrome maintained disease remission.

CONCLUSION:

Severe cases of Vogt-Koyanagi-Harada syndrome can be treated with early use of high-dose triple agent immunosuppressives.

• Authors: Mamta Agarwal, Sudha K Ganesh, Jyotirmay Biswas
• Journal: Ocular immunology and inflammation (Ocul Immunol Inflamm) Vol. 14 Issue 6 Pg. 333-9 (Dec 2006) ISSN: 0927-3948 [Print] England
• PMID: 17162603 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Glucocorticoids
• Immunosuppressive Agents
• Cyclosporine
• Prednisolone
• Azathioprine

Topics

• Adult
• Azathioprine (therapeutic use)
• Cyclosporine (therapeutic use)
• Drug Therapy, Combination
• Female
• Follow-Up Studies
• Fundus Oculi
• Glucocorticoids (therapeutic use)
• Humans
• Immunosuppressive Agents (therapeutic use)
• Middle Aged
• Ophthalmoscopy
• Prednisolone (therapeutic use)
• Remission Induction (methods)
• Retrospective Studies
• Uveomeningoencephalitic Syndrome (drug therapy, pathology)